Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,822 across all filing types
Latest filing 2021-03-02 Director's Dealing
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 100% confidence The document is titled 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons'. It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which governs the disclosure of insider/director dealings. While the text mentions an attachment, the document itself serves as the official announcement of these transactions, which falls under the 'Director's Dealing' category.
2021-03-02 English
Director's Dealing 2021
Director's Dealing Classification · 99% confidence The document is titled "Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons." It explicitly details trading activity (subscription of shares via warrant exercise) by a Member of the Board of Directors, citing compliance with Article 19 of Regulation No. 596/2014 (Market Abuse Regulation). This type of mandatory disclosure regarding personal share transactions by insiders (directors/managers) directly corresponds to the definition of Director's Dealing.
2021-03-02 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement regarding an increase in share capital resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, the impact on total share capital, and the regulatory context under the Danish Capital Markets Act. This falls squarely under the definition of a share issue or capital change announcement.
2021-03-02 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, and the resulting change in total share capital. This falls directly under the definition of a share issue or capital change announcement.
2021-03-02 English
6-K
Foreign Filer Report
2021-03-02 English
6-K
Foreign Filer Report
2021-03-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.